Bridges Investment Management Trimmed Its Goldman Sachs Group (GS) Holding; Sphera Funds Management LTD Has Upped By $4.70 Million Its Biogen (BIIB) Stake

January 15, 2018 - By Annabelle Johnson

Sphera Funds Management Ltd increased Biogen Inc (BIIB) stake by 16.67% reported in 2017Q3 SEC filing. Sphera Funds Management Ltd acquired 15,000 shares as Biogen Inc (BIIB)’s stock declined 13.45%. The Sphera Funds Management Ltd holds 105,000 shares with $32.88 million value, up from 90,000 last quarter. Biogen Inc now has $71.05B valuation. The stock increased 0.86% or $2.88 during the last trading session, reaching $335.95. About 885,516 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since January 15, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Bridges Investment Management Inc decreased Goldman Sachs Group Inc (GS) stake by 43.56% reported in 2017Q3 SEC filing. Bridges Investment Management Inc sold 4,313 shares as Goldman Sachs Group Inc (GS)’s stock declined 13.97%. The Bridges Investment Management Inc holds 5,589 shares with $1.33M value, down from 9,902 last quarter. Goldman Sachs Group Inc now has $96.95B valuation. The stock increased 0.74% or $1.9 during the last trading session, reaching $257.03. About 2.85M shares traded or 5.27% up from the average. The Goldman Sachs Group, Inc. (NYSE:GS) has risen 39.23% since January 15, 2017 and is uptrending. It has outperformed by 22.53% the S&P500.

Since January 9, 2018, it had 0 insider buys, and 1 sale for $1.92 million activity. PANGIA ROBERT W had sold 5,832 shares worth $1.92M on Tuesday, January 9.

Among 31 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 22 have Buy rating, 0 Sell and 9 Hold. Therefore 71% are positive. Biogen Idec Inc. has $450 highest and $268 lowest target. $352.97’s average target is 5.07% above currents $335.95 stock price. Biogen Idec Inc. had 95 analyst reports since July 23, 2015 according to SRatingsIntel. The company was maintained on Wednesday, August 17 by Morgan Stanley. Robert W. Baird maintained Biogen Inc. (NASDAQ:BIIB) rating on Friday, August 25. Robert W. Baird has “Hold” rating and $290.0 target. The firm has “Hold” rating by Jefferies given on Wednesday, October 5. The stock of Biogen Inc. (NASDAQ:BIIB) has “Strong-Buy” rating given on Tuesday, September 1 by Raymond James. The stock of Biogen Inc. (NASDAQ:BIIB) has “Hold” rating given on Tuesday, July 11 by Jefferies. The stock has “Buy” rating by H.C. Wainwright on Wednesday, July 26. The company was maintained on Friday, March 11 by Robert W. Baird. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Thursday, January 7 by Standpoint Research. The firm has “Hold” rating by Cantor Fitzgerald given on Tuesday, October 24. The rating was downgraded by Robert W. Baird to “Neutral” on Monday, July 27.

Sphera Funds Management Ltd decreased Array Biopharma Inc (NASDAQ:ARRY) stake by 295,000 shares to 405,000 valued at $4.98M in 2017Q3. It also reduced Global Blood Therapeutics In stake by 23,000 shares and now owns 127,000 shares. Retrophin Inc (NASDAQ:RTRX) was reduced too.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.25, from 0.88 in 2017Q2. It increased, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Fayez Sarofim & reported 9,713 shares stake. Hanson Mcclain reported 106 shares. Balasa Dinverno And Foltz Lc has invested 0.05% in Biogen Inc. (NASDAQ:BIIB). Empyrean Cap Prns Ltd Partnership owns 150,000 shares or 1.8% of their US portfolio. Amalgamated Commercial Bank stated it has 25,495 shares or 0.25% of all its holdings. Adell Harriman & Carpenter holds 6,226 shares or 0.43% of its portfolio. Cqs Cayman LP invested in 25,750 shares. Vantage Invest Ltd Limited Liability Company owns 172 shares for 0.01% of their portfolio. Prelude Cap Management Ltd Co reported 7,563 shares stake. State Of New Jersey Common Pension Fund D, New Jersey-based fund reported 218,485 shares. Epoch Inv Prns Inc invested 0.01% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Connable Office owns 5,736 shares. Covington Cap reported 239 shares. Bahl Gaynor holds 957 shares or 0% of its portfolio. Highvista Strategies Ltd Liability Company holds 33,409 shares.

Since August 1, 2017, it had 0 insider buys, and 6 insider sales for $15.08 million activity. $754,997 worth of stock was sold by SOLOMON DAVID M on Monday, August 7. GNODDE RICHARD J had sold 4,951 shares worth $1.19M. VINIAR DAVID A sold $1.05 million worth of stock. 17,685 The Goldman Sachs Group, Inc. (NYSE:GS) shares with value of $4.16 million were sold by ROGERS JOHN F.W.. The insider SCHWARTZ HARVEY M sold 25,000 shares worth $6.13M.

Bridges Investment Management Inc increased Costco Wholesale Corp (NASDAQ:COST) stake by 4,850 shares to 9,071 valued at $1.49 million in 2017Q3. It also upped Pepsico Inc Com (NYSE:PEP) stake by 43,661 shares and now owns 138,481 shares. Verizon Communications Com (NYSE:VZ) was raised too.

Among 30 analysts covering Goldman Sachs Group Inc. (NYSE:GS), 13 have Buy rating, 1 Sell and 16 Hold. Therefore 43% are positive. Goldman Sachs Group Inc. has $287 highest and $140 lowest target. $237.99’s average target is -7.41% below currents $257.03 stock price. Goldman Sachs Group Inc. had 90 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Tuesday, January 5 by Oppenheimer. The stock of The Goldman Sachs Group, Inc. (NYSE:GS) earned “Buy” rating by Keefe Bruyette & Woods on Wednesday, June 7. The company was upgraded on Monday, August 31 by Evercore. The firm has “Neutral” rating by UBS given on Monday, July 24. As per Tuesday, February 16, the company rating was upgraded by JP Morgan. Atlantic Securities upgraded The Goldman Sachs Group, Inc. (NYSE:GS) rating on Friday, April 21. Atlantic Securities has “Overweight” rating and $254 target. The stock of The Goldman Sachs Group, Inc. (NYSE:GS) earned “Sell” rating by Vertical Group on Monday, November 6. The rating was upgraded by Vetr on Monday, August 24 to “Buy”. As per Friday, October 6, the company rating was maintained by RBC Capital Markets. UBS maintained The Goldman Sachs Group, Inc. (NYSE:GS) on Friday, January 6 with “Buy” rating.

Analysts await The Goldman Sachs Group, Inc. (NYSE:GS) to report earnings on January, 17 before the open. They expect $5.10 earnings per share, up 0.39% or $0.02 from last year’s $5.08 per share. GS’s profit will be $1.92B for 12.60 P/E if the $5.10 EPS becomes a reality. After $5.02 actual earnings per share reported by The Goldman Sachs Group, Inc. for the previous quarter, Wall Street now forecasts 1.59% EPS growth.

Investors sentiment decreased to 0.75 in 2017 Q3. Its down 0.33, from 1.08 in 2017Q2. It is negative, as 63 investors sold GS shares while 427 reduced holdings. 82 funds opened positions while 285 raised stakes. 271.74 million shares or 2.47% less from 278.62 million shares in 2017Q2 were reported. Principal Financial reported 573,727 shares stake. Scotia Capital Inc invested in 0.06% or 17,912 shares. Duncker Streett & holds 6,957 shares. Saratoga And Invest Management has 0.13% invested in The Goldman Sachs Group, Inc. (NYSE:GS). Spirit Of America Mgmt Corp New York reported 0.08% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Quadrant Capital Mgmt Ltd Liability Company has invested 2.2% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Lenox Wealth Advisors stated it has 0% in The Goldman Sachs Group, Inc. (NYSE:GS). Hartford Invest Mgmt has 77,503 shares. Michigan-based Comerica Retail Bank has invested 0.18% in The Goldman Sachs Group, Inc. (NYSE:GS). Regentatlantic Cap accumulated 15,829 shares or 0.32% of the stock. Argentiere Cap Ag reported 13,500 shares stake. Zwj Investment Counsel Inc has invested 0.11% in The Goldman Sachs Group, Inc. (NYSE:GS). Horseman Mngmt owns 36,200 shares. National Bank Of Mellon has invested 0.24% in The Goldman Sachs Group, Inc. (NYSE:GS). Hanson & Doremus Inv holds 825 shares or 0.07% of its portfolio.